Exclusive: Death risk doubles for long A&E waits
Patients who spent more than 12 hours in A&E were twice as likely to die within 30 days as those treated, transferred or discharged within two hours, a landmark study shared with HSJ reveals.
Patients who spent more than 12 hours in A&E were twice as likely to die within 30 days as those treated, transferred or discharged within two hours, a landmark study shared with HSJ reveals.
Background Health systems across Europe are facing a workforce crisis, with some experiencing severe shortages of doctors. In response, many are exploring greater task-sharing, across…
Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.
This is the first qualitative study evaluating the experiences of Latinas throughout medical training, revealing that they experience disproportionate barriers and discriminatory experiences from both…
Background The percentage of physicians identifying as Latina has not improved despite improvements in recruitment of Latina medical students, suggesting barriers to retention and career…
An official journal of the British Society for Haematology, the British Journal of Haematology offers high visibility for clinical, basic and translational research.
On Jan. 15, 2025, the FDA approved sotorasib (Lumakras, Amgen Inc.) with panitumumab (Vectibix, Amgen Inc.) for KRAS G12C-mutated metastatic colorectal cancer.
Background Health systems across Europe are facing a workforce crisis, with some experiencing severe shortages of doctors. In response, many are exploring greater task-sharing, across…
Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive disease after neoadjuvant systemic therapy have a high risk of…
Our dear friends, the Bardia family—Aditya, his wife (Vibha), and their two… Mina Sedrak needs your support for Support the Bardia Family After Palisades Fire
The development of new therapeutic strategies such as immune checkpoint inhibitors (ICIs) and targeted therapies has increased the complexity of the treatment landscape for solid…